The DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Effects of the acute administration of caffeine in patients with schizophrenia
Abstract
Caffeine, 10 mg/kg, was administered to 13 schizophrenic patients in a double-blind placebo-controlled study of its behavioral effects. Some measures of psychopathology were significantly increased: Brief Psychiatric Rating Scale (BPRS) total, BPRS subscales thought disorder, unusual thought content, and euphoria-activation, and several individual BPRS items. Nurses' Bunney-Hamberg ratings of psychosis and mania, comparing the day before with the day after pharmacological challenge, increased significantly. Compared to placebo, caffeine also produced significant increases of diastolic blood pressure and cortisol. Thus, these findings indicate that caffeine increases arousal and has a psychotogenic effect when administered to schizophrenic patients. The possible roles of various neurotransmitters is discussed with special emphasis on caffeine's actions on dopaminergic and adenosinergic systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For other mental illness, such as schizophrenia, caffeine may exacerbate psychotic symptoms (209), although the majority of this literature is informed by case studies, with very few double-blind placebo-controlled studies (210).”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [209]
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,862
The Two-syndrome Concept: Origins and Current Status
Crow, T. J. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.471 · Cited by 841
Bruns, R. F., Daly, J. W., & Snyder, S. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5547 · Cited by 549
Tolerance to the humoral and hemodynamic effects of caffeine in man.
Robertson, D., Wade, D., Workman, R., Woosley, R. L., & Oates, J. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110124 · Cited by 501
Methods for Reliable Longitudinal Observation of Behavior
Bunney, W. E. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720150090010 · Cited by 480
Increased Anxiogenic Effects of Caffeine in Panic Disorders
Charney, D. S. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260027003 · Cited by 428
Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate
Janowsky, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750320023004 · Cited by 310
Methylphenidate, Dextroamphetamine, and Levamfetamine
Janowsky, D. S. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030024003 · Cited by 205
Increased Sensitivity to Caffeine in Patients With Panic Disorders
Boulenger, J. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220057009 · Cited by 193
Cited by
Sorted by citations
Items 101–125 of 125
Caffeine and clinical change in a patient with schizophrenia on a long-stay ward
Kim, A., & O'Hanlon, M. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700011988 · Cited by 2
Síntomas psicóticos y consumo de bebidas energizantes: Reporte de caso
Valdivieso-Jiménez, G. (2022) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272022000300308 · Cited by 2
Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia
Lagreula, J., Ferraiolo, M., de Timary, P., Delatte, B., Elens, L., Hermans, E., & Dalleur, O. (2023) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001670 · Cited by 2
Childs, E., & de Wit, H. (2012) · Wiley eBooks · doi:10.1002/9781119949893.ch17 · Cited by 2
Janho, M. B., Papaliaga, M., Samara, A. A., Papoutsopoulou, S., Speletas, M. G., Christodoulou, N., & Asprodini, E. K. (2026) · Brain Sciences · doi:10.3390/brainsci16020209 · Cited by 1
New-Onset Psychosis: Check Caffeine Use
Whiting, W. L. (2011) · Current psychiatry · Cited by 1
Caffeine Misuse and Weight Loss
Ramacciotti, C., Coli, E., & Burgalassi, A. (2016) · Palgrave Macmillan UK eBooks · doi:10.1057/978-1-137-53535-1_5 · Cited by 1
Caffeine Restrictions in Inpatient Psychiatric Settings: Precipitating Withdrawal?
Shapiro, B. B. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000571 · Cited by 1
Lavan, D., Watt, S., & Crowe, S. F. (2016) · Journal of Caffeine Research · doi:10.1089/jcr.2016.0001 · Cited by 1
A STUDY OF SMOKING BEHAVIOUR AMONG MALES WITH SCHIZOPHRENIA
Thirumalai, R. (2017) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2017/762 · Cited by 1
Elevated blood pressure may cause volume reductions of temporal areas and induce psychotic episodes
Niederhofer, H. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.037 · Cited by 1
Naturally Occurring Toxicants and Food Constituents of Toxicological Interest
Gosting, D. C., Doyle, M. E., Steinhart, C. E., & Cochrane, B. A. (1991) · Elsevier eBooks · doi:10.1016/b978-0-7506-9210-6.50010-4 · Cited by 1
Xanthines (Caffeine) and Nicotine
Schuckit, M. A. (1989) · Springer eBooks · doi:10.1007/978-1-4757-0767-0_12
Das Gesundheitsverhalten schizophren erkrankter Patienten: ein typisches Verhaltensmuster?
Fritz-Wieacker, A., Roick, C., Schindler, J., Frühwald, S., & Riedel-Heller, S. G. (2009) · Das Gesundheitswesen · doi:10.1055/s-0029-1239271
No anti-ACTH autoantibody in serum of SARS patients
Li, J., Gao, J., & Lou, J.-N. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.031
Sonstige psychotrope Substanzen
Deckert, J., Gleiter, C. H., Schmidt, L., Huether, G., Rüther, E., Dietmaier, O., & Laux, G. (2007) · Springer eBooks · doi:10.1007/3-211-37774-3_5
Relationship to Psychopathology and Medication Side Effects
GOFF, D. C., Henderson, D. C., & AMICO, E. T. (1992)
Suggestions for Treatment of Schizophrenia
Beyer, A. C. (2019) · doi:10.35248/2168-975x.19.8.251
Novos usos para medicações psicotrópicas conhecidas
Bisol, L. W. (2008) · Americanae (AECID Library)
Platz, W. E., Böning, J., Wesemann, W., Weiner, N., Hartmann, A., Deckert, J., & Gleiter, C. H. (1992) · Springer eBooks · doi:10.1007/978-3-7091-3793-2_5
Xanthines (Caffeine) and Nicotine
Schuckit, M. A. (1995) · Springer eBooks · doi:10.1007/978-1-4757-2407-3_12
Jawad, A., Mtairek, M. A., Awde, M. H., Kanso, H., Kawssan, A., Awada, R., Khadra, T., Moselmani, M., Tarhini, Z. M., Bazzal, A. A., et al. (2024) · Progress in brain research · doi:10.1016/bs.pbr.2024.06.004
Wong, Z. Z. B., Soh, Q. X., Mau, A. W. K., Xia, W. H., & Soh, Q. R. (2026) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2026.2672448
BLOQUEIO ADENOSINÉRGICO E FILTRO SENSORIAL
Ghisolfi, E. S. (2002) · Americanae (AECID Library)
Metadata
- Authors
- Lucas, P. B., Pickar, D., Kelsoe, J., Rapaport, M., Pato, C., & Hommer, D.
- Affiliations
- National Institute of Mental Health (US)
- Corresponding author
- Pickar, David
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 1990-07
- Volume
- 28
- Issue
- 1
- Pages
- 35-40
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1979225061
- Cited by
- 125
- References
- 29
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 4 · 2017: 7 · 2016: 2 · 2015: 5 · 2014: 4 · 2013: 1 · 2012: 4
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, schizophrenia, psychopathology, arousal, psychosis, mania, blood pressure, cortisol, dopaminergic system, adenosinergic system, neurotransmitters
- MeSH terms
- Adolescent, Adult, Arousal, Caffeine, Female, Humans, Hydrocortisone, Male, Psychiatric Status Rating Scales, Schizophrenia, Schizophrenic Psychology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review